Platelet PECAM-1 inhibits thrombus formation in vivo

Blood

Volumn 107, Issue 2, 2006, Pages 535-541

  Falati, Shahrokh ^b   Patil, Sonali ^b   Gross, Peter L ^b   Stapleton, Michelle ^b   Merrill Skoloff, Glenn ^b   Barrett, Natasha E ^b   Pixton, Katherine L ^b   Weiler, Harmut ^b   Cooley, Brian ^b   Newman, Debra K ^b   Newman, Peter J ^b   Furie, Barbara C ^b   Furie, Bruce ^b   Gibbins, Jonathan M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CELL SURFACE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CAROTID ARTERY THROMBOSIS; CHIMERA; CONTROLLED STUDY; CREMASTER MUSCLE; FUNCTIONAL PROTEOMICS; IN VIVO STUDY; INHIBITION KINETICS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOGENESIS;

EID: 30444452396     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-04-1512     Document Type: Article

References (60)

1. Ohto H, Maeda H, Shibata Y, et al. A novel leukocyte differentiation antigen: two monoclonal antibodiesTM2 and TM3 define 120-kDa molecule present on neutrophils, monocytes, platelets, and activated lymphoblasts. Blood. 1985;66:873-881.
2. Muller WA, Ratti CM, McDonnell SL, Cohn ZA. A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intracellular junctions. J Exp Med. 1989;178:449-460.
3. Albelda SM, Muller WA, Buck CA, Newman PJ. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol. 1991;114:1059-1068.
4. Newman PJ, Berndt MJ, Gorski J, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science. 1990;247:1219-1222.
5. Vaporciyan AA, DeLisser HM, Yan H-C, et al. Involvement of platelet-endothelial cell adhesion molecule-1 in neutriphil recruitment in vivo. Science. 1993;262:1580-1582.
6. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med. 1993;178:449-460.
7. Duncan GS, Andrew DP, Takimoto H, et al. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol. 1999;162:3022-3030.
8. Tanaka Y, Albelda SM, Horgan KJ, et al. CD31 expressed on distinctive T cell subsets is a preferential amplifier of b1 integrin-mediated adhesion. J Exp Med. 1992;176:245-253.
9. Leavesley DI, Oliver JM, Swart BW, Berndt MC, Haylock DN, Simmons PJ. Signals from platelet endothelial-cell adhesion molecule enhance the adhesive activity of the very late antigen-4 integrin of human Cd34(+) hematopoietic progenitor cells. J Immunol. 1994;153:4673-4683.
10. Piali L, Albelda SM, Baldwin HS, Hammel P, Gisler RH, Imhof BA. Murine platelet endothelial cell adhesion molecule (PECAM-1/CD31) modulates β2 integrins on lymphokine-activated killer cells. Eur J Immunol. 1993;23:2464-2471.
11. Berman ME, Muller WA. Ligation of platelet endothelial-cell adhesion molecule-1 (Pecam-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte Cr3 (CD11b/CD18). J Immunol. 1995;154:299-307.
12. Berman ME, Xie Y, Muller WA. Roles of platelet endothelial cell adhesion molecule-1 (PECAM- 1, CD31) in natural killer cell transendothelial migration and beta(2) integrin activation. J Immunol. 1996;156:1515-1524.
13. Varon D, Jackson DE, Shenkman B, et al. Platelet/endothelial cell adhesion molecule-1 serves as a co-stimulatory agonist receptor that modulates integrin dependent adhesion and aggregation of human platelets. Blood. 1998;91:500-507.
14. Chiba R, Nakagawa N, Kuroasawa K, Tanaka Y, Saito Y, Iwamoto I. Ligation of CD31(PECAM-1) on endothelial cells increases adhesive function of ανβ3 integrin and enhances β1 integrin mediated adhesion of eosinophilis to endothelial cells. Blood. 1999;94:1319-1329.
15. Reedquist KA, Ross E, Koop EA, et al. The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J Cell Biol. 2000;148:1151-1158.
16. Zhao TM, Newman PJ. Integrin activation by regulated dimerization and oligomerization of platelet endothelial cell adhesion molecule (PECAM)-1 from within the cell. J Cell Biol. 2001;152:65-73.
17. Newton-Nash DK, Newman PJ. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. J Immunol. 1999;163:682-688.
18. Newman DK, Hamilton C, Newman PJ. Inhibition of antigen-receptor signaling by platelet endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck). Blood. 2001;97:2351-2357.
19. Wilkinson R, Lyons AB, Roberts D, Wong MX, Bartley PA, Jackson DE. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell development, B-cell antigen receptor (BCR)-mediated activation, and autoimmune disease. Blood. 2002;100:184-193.
20. Brier G, Brevario F, Caveda L, et al. Molecular cloning and expression of murine vascular endothelial cdherin in early stage development of the cardiovascular system. Blood. 1996;87:630-641.
21. Gao CJ, Sun WY, Christofidou-Solomidou M, et al. PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis. Blood. 2003;102:169-179.
22. Brown S, Heinisch I, Ross E, Shaw K, Buckley CD, Savill J. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature. 2002;418:200-203.
23. Maas M, Stapleton M, Bergom C, Mattson DL, Newman DK, Newman PJ. Endothelial cell PECAM-1 confers protection against endotoxic shock. Am J Physiol Heart Circ Physiol. 2005;288:H159-H164.
24. Cicmil M, Thomas JM, Leduc M, Bon C, Gibbins JM. PECAM-1 signalling inhibits the activation of human platelets. Blood. 2002;99:137-144.
25. Jones KL, Hughan SC, Dopheide SM, Farndale RW, Jackson SP, Jackson DE. Platelet endothelial cell adhesion molecule-1 is a negative regulator of platelet-collagen interactions. Blood. 2001;98:1456-1463.
26. Patil S, Newman DK, Newman PJ. Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. Blood. 2001;97:1727-1732.
27. Sun QH, DeLisser HM, Zukowski MM, Paddock C, Albelda SM, Newman PJ. Individually distinct Ig homology domains in PECAM-1 regulate hemophilic binding and modulate receptor affinity. J Biol Chem. 1996;271:11090-11098.
28. Sun J, Williams J, Yan H-C, Amin KM, Albelda SM, DeLisser HM. Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilin adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression. J Biol Chem. 1996;271:18561-18570.
29. Newton JP, Buckley CD, Jones EY, Simmons DL. Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites of PECAM-1/CD31. J Biol Chem. 1997;272:20555-20563.
30. Buckley CD, Doyonnas R, Newton JP, et al. Identification of ανβ3 as a heterotypic ligand for CD31/PECAM-1. J Cell Sci. 1996;109:437-445.
31. Deaglio S, Morra M, Mallone R, et al. Human CD38 (ADP-Ribosyl Cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol. 1998;160:395-402.
32. Burshtyn DN, Yang WT, Yi TL, Long EO. A novel phosphotyrosine motif with a critical amino acid at position-2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1. J Biol Chem. 1997;272:13066-13072.
33. Cicmil M, Thomas JM, Sage T, et al. Collagen, convulxin, and thrombin stimulate aggregation-independent tyrosine phosphorylation of CD31 in platelets: evidence for the involvement of Src family kinases. J Biol Chem. 2000;275:27339-27347.
34. Jackson DE, Kupcho KR, Newman PJ. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2. J Biol Chem. 1997;272:24868-24875.
35. Hua CT, Gamble JR, Vadas MA, Jackson DE. Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1): identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates. J Biol Chem. 1998;273:28332-28340.
36. Jackson DE, Ward CM, Wang R, Newman PJ. The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. J Biol Chem. 1997;272:6986-6993.
37. Rosenblum WI, Murata S, Nelson GH, Werner PK, Ranken R, Harmon RC. Anti-Cd31 delays platelet adhesion/aggregation at sites of endothelial injury in mouse cerebral arterioles. Am J Pathol. 1994;145:33-36.
38. Rosenblum WI, Nelson GH, Wormley B, Werner P, Wang J, Shih CC-Y. Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo. Stroke. 1996;27:709-711.
39. Vollmar B, Schmits R, Kunz D, Menger MD. Lack of in vivo function of CD31 in vascular thrombosis. Thromb Haemost. 2001;85:160-164.
40. Falati S, Gross P, Merrill-Skoloff G, Furie BC, Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med. 2002;8:1175-1180.
41. Dubois C, Panicot-Dubois L, Furie B, Furie BC. Importance of GPVI in platelet activation and thrombus formation in vivo [abstract]. Blood. 2004;104:240a. Abstract 842.
42. Day SM, Reeve JL, Myers DD, Fay WP. Murine thrombosis models. Thromb Haemost. 2004;92:486-494.
43. Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric-chloride. Thromb Res. 1990;60:269-280.
44. Farrehi PM, Ozaki CK, Carmeliet P, Fay WP. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation. 1998;97:1002-1008.
45. Lyle EM, Lewis SD, Lehman ED, Gardell SJ, Motzel SL, Lynch JJ. Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis. Thromb Haemost. 1998;79:656-662.
46. Gibbins J, Asselin J, Farndale R, Barnes M, Law CL, Watson SP. Tyrosine phosphorylation of the Fc receptor gamma-chain in collagen-stimulated platelets. J Biol Chem. 1996;271:18095-18099.
47. Gibbins JM, Okuma M, Farndale R, Barnes M, Watson SP. Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor γ-chain. FEBS Lett. 1997;413:255-259.
48. Poole A, Gibbins JM, Turner M, et al. The Fc receptor γ-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J. 1997;16:2333-2341.
49. Yanaga F, Poole A, Asselin J, et al. Syk interacts with tyrosine-phosphorylated proteins in human platelets activated by collagen and cross-linking of the Fcγ-IIA receptor. Biochem J. 1995;311:471-478.
50. Falati S, Edmead CE, Poole AW. Glycoprotein Ib-V-IX, a receptor for von Willebrand factor, couples physically and functionally to the Fc receptor gamma- chain, Fyn, and Lyn to activate human platelets. Blood. 1999;94:1648-1656.
51. Marshall SJ, Asazuma N, Best D, et al. Glycoprotein IIb-IIIa-dependent aggregation by glycoprotein Ib alpha is reinforced by a Src family kinase inhibitor (PP1)-sensitive signalling pathway. Biochem J. 2002;361:297-305.
52. Rathore V, Stapleton MA, Hillery CA, et al. PECAM-1 negatively regulates GPIb/V/IX signaling in murine platelets. Blood. 2003;102:3658-3664.
53. Thai LM, Ashman LK, Harbour SN, Hogarth PM, Jackson DE. Physical proximity and functional interplay of PECAM-1 with the Fc receptor Fc gamma RIIa on the platelet plasma membrane. Blood. 2003;102:3637-3645.
54. Mahooti S, Graesser D, Patil S, et al. PECAM-1 (CD31) expression modulates bleeding time in vivo. Am J Pathol. 2000;157:75-81.
55. Falati S, Liu QD, Gross P, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med. 2003;197:1585-1598.
56. Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie BC, Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood. 2004;104:3190-3197.
57. Day SM, Reeve JL, Pedersen B, et al. Macrovscular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood. 2005;105:192-198.
58. Rosen ED, Raymond S, Zollman A, et al. Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi. Am J Pathol. 2001;158:1613-1622.
59. Sim DS, Merrill-Skoloff G, Furie BC, Furie B, Flaumenhaft R. Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levels. Blood. 2004;103:2127-2134.
60. Gurubhagavatula I, Amrani Y, Practico D, Ruberg FL, Albelda SM, Panettieri RA. Engagement of human PECAM-1 (CD31) on human endothelial cells increases intracellular calcium ion concentration and stimulates prostacyclin release. J Clin Invest. 1998;101:212-222.